Anand Patel to Disease Management
This is a "connection" page, showing publications Anand Patel has written about Disease Management.
Connection Strength
1.759
-
Treatment of Anemia in Lower-Risk Myelodysplastic Syndrome. Curr Treat Options Oncol. 2024 Jun; 25(6):752-768.
Score: 0.747
-
SOHO State of the Art Updates and Next Questions | Challenging Scenarios in the Management of Myeloproliferative Neoplasms. Clin Lymphoma Myeloma Leuk. 2025 Jul; 25(7):484-493.
Score: 0.196
-
Prevention and treatment of transformation of myeloproliferative neoplasms to acute myeloid leukemia. Haematologica. 2025 Apr 01; 110(4):828-839.
Score: 0.192
-
Genomics of MPN progression. Hematology Am Soc Hematol Educ Program. 2020 12 04; 2020(1):440-449.
Score: 0.147
-
The Next Generation of JAK Inhibitors: an Update on Fedratinib, Momelotonib, and Pacritinib. Curr Hematol Malig Rep. 2020 12; 15(6):409-418.
Score: 0.147
-
Biology and Treatment Paradigms in T Cell Acute Lymphoblastic Leukemia in Older Adolescents and Adults. Curr Treat Options Oncol. 2020 05 28; 21(7):57.
Score: 0.142
-
Clinical and Biological Prognostic Factors in Follicular Lymphoma. Hematol Oncol Clin North Am. 2020 08; 34(4):647-662.
Score: 0.141
-
NCCN Guidelines® Insights: Systemic Mastocytosis, Version 3.2024. J Natl Compr Canc Netw. 2024 06; 22(2 D).
Score: 0.047